- Home
- HCTI vs LPCN Comparison
HCTI vs LPCN Comparison
Compare HCTI & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCTI
- LPCN
- Stock Information
- Founded
- HCTI 2020
- LPCN 1997
- Country
- HCTI United States
- LPCN United States
- Employees
- HCTI N/A
- LPCN N/A
- Industry
- HCTI Retail: Computer Software & Peripheral Equipment
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- HCTI Technology
- LPCN Health Care
- Exchange
- HCTI Nasdaq
- LPCN Nasdaq
- Market Cap
- HCTI 13.5M
- LPCN 16.1M
- IPO Year
- HCTI 2021
- LPCN N/A
- Fundamental
- Price
- HCTI $0.03
- LPCN $3.10
- Analyst Decision
- HCTI
- LPCN Strong Buy
- Analyst Count
- HCTI 0
- LPCN 2
- Target Price
- HCTI N/A
- LPCN $9.00
- AVG Volume (30 Days)
- HCTI 709.7M
- LPCN 60.6K
- Earning Date
- HCTI 08-18-2025
- LPCN 08-07-2025
- Dividend Yield
- HCTI N/A
- LPCN N/A
- EPS Growth
- HCTI N/A
- LPCN N/A
- EPS
- HCTI N/A
- LPCN N/A
- Revenue
- HCTI $11,291,000.00
- LPCN $3,674,834.00
- Revenue This Year
- HCTI N/A
- LPCN N/A
- Revenue Next Year
- HCTI N/A
- LPCN N/A
- P/E Ratio
- HCTI N/A
- LPCN N/A
- Revenue Growth
- HCTI N/A
- LPCN N/A
- 52 Week Low
- HCTI $0.01
- LPCN $2.68
- 52 Week High
- HCTI $1.90
- LPCN $8.23
- Technical
- Relative Strength Index (RSI)
- HCTI 41.79
- LPCN 43.66
- Support Level
- HCTI $0.02
- LPCN $3.13
- Resistance Level
- HCTI $0.03
- LPCN $3.23
- Average True Range (ATR)
- HCTI 0.01
- LPCN 0.17
- MACD
- HCTI 0.01
- LPCN -0.01
- Stochastic Oscillator
- HCTI 38.89
- LPCN 15.69
About HCTI Healthcare Triangle Inc.
Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Platform Services.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.